Trials / Completed
CompletedNCT05154968
A Study of Two Formulations (Both Refrigerated and Room Temperature) Using an Autoinjector Device in Healthy Participants
A Study to Evaluate Injection-Site Pain of Two Formulations (Both Refrigerated and Room Temperature) Using an Autoinjector Device in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The main purpose of the study is to assess the injection site pain intensity of two formulations using prefilled autoinjector device in healthy participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sodium chloride | Administered SC infusion. |
| DRUG | Citrate buffer | Administered SC infusion. |
| DRUG | Mannitol | Administered SC infusion. |
| DEVICE | Prefilled Autoinjector | Used to administer the drug through SC infusion. |
Timeline
- Start date
- 2021-11-24
- Primary completion
- 2021-12-14
- Completion
- 2021-12-14
- First posted
- 2021-12-13
- Last updated
- 2022-01-13
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05154968. Inclusion in this directory is not an endorsement.